Food and Drug Administration

The cannabis sector is excited for several major catalysts that could help provide momentum after setbacks. Alongside the SAFER Banking Act in the Senate that could help provide financing to cannabis sectors, the potential reclassification of marijuana as a Schedule 1 substance could create...

On August 29, 2023, the U.S. Department of Health and Human Services (HHS) recommended the DEA reclassify marijuana and move it from Schedule I to Schedule III, following a review by the Food and Drug Administration (FDA), as part of a process initiated by President Joe Biden in...

Logan Paul's PRIME, the YouTuber's popular energy drink, has responded to Senate Majority Leader Chuck Schumer's call for an FDA investigation into PRIME. The energy drink, created by Paul, the American social media personality, actor, and professional wrestler, along with the...

U.S. Senate Majority Leader Chuck Schumer has called for an investigation into PRIME, a popular energy drink created by YouTube stars Logan Paul and KSI. Schumer expressed concerns over the drink’s high caffeine content and its marketing towards children, Reuters reports. High Caffeine...

The U.S. Supreme Court has halted a Texas judge's restrictions on a widely used abortion pill, allowing it to remain on the market.  On Friday, the high court granted emergency requests by the Justice Department and mifepristone manufacturer Danco Laboratories to put on...

A U.S. judge in Texas has suspended the government's decades-old approval of the abortion pill mifepristone, which terminates a pregnancy within the first 10 weeks. On Friday, Judge Matthew Kacsmaryk of the U.S. Northern District of Texas, who was appointed to the bench by...

The medical cannabis industry in Utah is confusing since synthetic cannabinoid-laden products appeared in naturally abundant amounts on dispensary shelves. According to the FDA, CBD is synthesized from delta-8, THC and a variety of other cannabinoids that could pose "serious...

The Hawaii Department of Health (DOH) and Hawaii Department of Public Safety (PSD) conducted operations to execute search warrants and to embargo products at several retail stores including a CBD dispensary in Honolulu, reported Marijuana Moment. “We want to make sure businesses...

The U.S. government could be speeding up a plan to ban menthol cigarettes, according to a new report. Here’s the new timeline and two stocks that could be affected. What Happened: The Biden Administration could advance a ban on menthol cigarettes, according to a Wall Street Journal...

Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big pharma earnings. The sector came back up in the final session for a firm finish. Merck &...

After a fairly robust 2021, the new year started on a mixed note as far as regulatory decisions are concerned. About three new molecular entities, or NMEs, were approved during the month, including Immunocore Holdings plc's (NASDAQ: IMCR) Kimmtrak for certain patients with advanced eye...

As more and more states embrace the cannabis plant in its “full form,” some still challenge the legality of hemp-based products. Cannabis company Hometown Hero filed a suit against the Texas Department of State Health Services (DSHS) last week claiming that its hemp...

Year-end reviews by the Food and Drug Administration produced mostly positive outcomes, with most therapies passing the regulatory hurdle without any hiccups. Despite the problems posed by the pandemic for the conduct of clinical trials and regulatory inspections of facilities, the biopharma sector...

After initial reports emerged on Saturday about a potential acquisition deal, Gilead Sciences Inc (NASDAQ: GILD) confirmed that it's set to purchase Immunomedics Inc (NASDAQ: IMMU). According to a company statement on Sunday, Gilead is anticipating the close of this definitive...

Pfizer Inc (NYSE: PFE) and its German partner BioNTech SE (NASDAQ: BNTX) said Saturday they are seeking the United States Food and Drug Administration approval to expand the late-stage clinical trial of their COVID-19 vaccine, by significantly upping the number of participants and increasing their...